vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Whitestone REIT (WSR). Click either name above to swap in a different company.

Whitestone REIT is the larger business by last-quarter revenue ($43.9M vs $40.7M, roughly 1.1× PETMED EXPRESS INC). Whitestone REIT runs the higher net margin — 52.0% vs -26.0%, a 78.0% gap on every dollar of revenue. On growth, Whitestone REIT posted the faster year-over-year revenue change (7.5% vs -23.3%). Whitestone REIT produced more free cash flow last quarter ($50.5M vs $-9.2M). Over the past eight quarters, Whitestone REIT's revenue compounded faster (8.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.

PETS vs WSR — Head-to-Head

Bigger by revenue
WSR
WSR
1.1× larger
WSR
$43.9M
$40.7M
PETS
Growing faster (revenue YoY)
WSR
WSR
+30.8% gap
WSR
7.5%
-23.3%
PETS
Higher net margin
WSR
WSR
78.0% more per $
WSR
52.0%
-26.0%
PETS
More free cash flow
WSR
WSR
$59.7M more FCF
WSR
$50.5M
$-9.2M
PETS
Faster 2-yr revenue CAGR
WSR
WSR
Annualised
WSR
8.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
WSR
WSR
Revenue
$40.7M
$43.9M
Net Profit
$-10.6M
$22.8M
Gross Margin
23.3%
Operating Margin
-25.7%
53.0%
Net Margin
-26.0%
52.0%
Revenue YoY
-23.3%
7.5%
Net Profit YoY
-1392.6%
31.7%
EPS (diluted)
$-0.50
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
WSR
WSR
Q4 25
$40.7M
$43.9M
Q3 25
$44.4M
$41.0M
Q2 25
$51.2M
$37.9M
Q1 25
$50.8M
$38.0M
Q4 24
$52.0M
$40.8M
Q3 24
$58.0M
$38.6M
Q2 24
$66.2M
$37.6M
Q1 24
$65.1M
$37.2M
Net Profit
PETS
PETS
WSR
WSR
Q4 25
$-10.6M
$22.8M
Q3 25
$-8.5M
$18.3M
Q2 25
$-34.2M
$5.1M
Q1 25
$-11.6M
$3.7M
Q4 24
$-707.0K
$17.3M
Q3 24
$2.3M
$7.6M
Q2 24
$3.8M
$2.6M
Q1 24
$-5.0M
$9.3M
Gross Margin
PETS
PETS
WSR
WSR
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
WSR
WSR
Q4 25
-25.7%
53.0%
Q3 25
-18.9%
45.5%
Q2 25
-66.7%
13.8%
Q1 25
-11.9%
10.2%
Q4 24
-0.9%
43.3%
Q3 24
1.0%
20.3%
Q2 24
6.6%
7.2%
Q1 24
-5.9%
25.9%
Net Margin
PETS
PETS
WSR
WSR
Q4 25
-26.0%
52.0%
Q3 25
-19.2%
44.7%
Q2 25
-66.7%
13.3%
Q1 25
-22.9%
9.7%
Q4 24
-1.4%
42.5%
Q3 24
4.0%
19.7%
Q2 24
5.7%
6.9%
Q1 24
-7.7%
25.1%
EPS (diluted)
PETS
PETS
WSR
WSR
Q4 25
$-0.50
$0.43
Q3 25
$-0.41
$0.35
Q2 25
$-1.65
$0.10
Q1 25
$-0.56
$0.07
Q4 24
$-0.03
$0.34
Q3 24
$0.11
$0.15
Q2 24
$0.18
$0.05
Q1 24
$-0.24
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
WSR
WSR
Cash + ST InvestmentsLiquidity on hand
$26.9M
$4.9M
Total DebtLower is stronger
$649.4M
Stockholders' EquityBook value
$32.8M
$458.1M
Total Assets
$88.0M
$1.2B
Debt / EquityLower = less leverage
1.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
WSR
WSR
Q4 25
$26.9M
$4.9M
Q3 25
$36.1M
$6.8M
Q2 25
$41.1M
$5.3M
Q1 25
$54.7M
$5.6M
Q4 24
$50.1M
$5.2M
Q3 24
$52.0M
$2.5M
Q2 24
$46.0M
$3.2M
Q1 24
$55.3M
$6.2M
Total Debt
PETS
PETS
WSR
WSR
Q4 25
$649.4M
Q3 25
Q2 25
Q1 25
Q4 24
$632.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PETS
PETS
WSR
WSR
Q4 25
$32.8M
$458.1M
Q3 25
$43.1M
$439.5M
Q2 25
$51.5M
$427.5M
Q1 25
$85.1M
$431.0M
Q4 24
$96.2M
$438.2M
Q3 24
$96.4M
$419.5M
Q2 24
$93.5M
$418.3M
Q1 24
$96.7M
$421.6M
Total Assets
PETS
PETS
WSR
WSR
Q4 25
$88.0M
$1.2B
Q3 25
$100.3M
$1.1B
Q2 25
$109.8M
$1.2B
Q1 25
$148.7M
$1.1B
Q4 24
$144.8M
$1.1B
Q3 24
$146.0M
$1.1B
Q2 24
$152.7M
$1.1B
Q1 24
$169.9M
$1.1B
Debt / Equity
PETS
PETS
WSR
WSR
Q4 25
1.42×
Q3 25
Q2 25
Q1 25
Q4 24
1.44×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
WSR
WSR
Operating Cash FlowLast quarter
$-9.2M
$50.8M
Free Cash FlowOCF − Capex
$-9.2M
$50.5M
FCF MarginFCF / Revenue
-22.7%
114.9%
Capex IntensityCapex / Revenue
0.1%
0.7%
Cash ConversionOCF / Net Profit
2.22×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
WSR
WSR
Q4 25
$-9.2M
$50.8M
Q3 25
$-2.2M
$18.0M
Q2 25
$-12.3M
$13.8M
Q1 25
$7.0M
$3.1M
Q4 24
$-1.2M
$58.2M
Q3 24
$7.4M
$16.4M
Q2 24
$-8.5M
$12.3M
Q1 24
$7.1M
$11.5M
Free Cash Flow
PETS
PETS
WSR
WSR
Q4 25
$-9.2M
$50.5M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
$58.0M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
PETS
PETS
WSR
WSR
Q4 25
-22.7%
114.9%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
142.1%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
PETS
PETS
WSR
WSR
Q4 25
0.1%
0.7%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
0.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
PETS
PETS
WSR
WSR
Q4 25
2.22×
Q3 25
0.98×
Q2 25
2.74×
Q1 25
0.83×
Q4 24
3.36×
Q3 24
3.18×
2.15×
Q2 24
-2.27×
4.73×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

WSR
WSR

Segment breakdown not available.

Related Comparisons